Cardiac adverse events associated with chimeric antigen receptor T- cell therapy

Am J Emerg Med. 2022 Jul:57:225-226. doi: 10.1016/j.ajem.2022.02.040. Epub 2022 Feb 23.

Authors

Sahith Reddy Thotamgari¹, Udhayvir Singh Grewal¹, Likhita Shaik², Paari Dominic³

Affiliations

¹ Department of Internal Medicine, Louisiana State University Health Sciences Center, Shreveport, LA, United States of America.
² Department of Family Medicine, Hennepin Healthcare, Minneapolis, MN, United States of America.
³ Division of Cardiology, Department of Medicine, Louisiana State University Health Sciences Center, Shreveport, LA, United States of America. Electronic address: pdomi2@lsuhsc.edu.

PMID: 35227547
DOI: 10.1016/j.ajem.2022.02.040

No abstract available

Publication types

Letter
Comment

MeSH terms

Cell- and Tissue-Based Therapy
Humans
Immunotherapy, Adoptive / adverse effects
Receptors, Chimeric Antigen*

Substances

Receptors, Chimeric Antigen